Background. A study of tissue kallikrein excretion in African women with se
vere pre-eclampsia.
Methods. Random untimed urine samples were collected from all women (n = 19
8) recruited to this study; 66 women with severe pre-eclampsia, 66 normoten
sive pregnant women of similar length of gestation and 66 normotensive non-
pregnant women. Urine specimens were analyzed for urinary tissue kallikrein
using a selective, synthetic chromogenic tripeptide substrate (S2266) havi
ng the sequence H-D-Val-Leu-Arg-pNA.
Results. Urinary tissue kallikrein levels were decreased in women with seve
re pre-eclampsia compared with those of gestation matched normotensive preg
nant women at 28 weeks of gestation (1.55+/-0.95 vs. 3.02+/-1.35 ng TK/mu g
protein; p < 0.0001) and at near delivery date (1.21 +/- 0.53 vs. 3.11 +/-
1.21 ng TK/mu g protein; p < 0.0001). In the normotensive pregnant group,
there was no significance difference in urinary tissue kallikrein excretion
close at delivery date compared to 28 weeks of gestation (3.02 +/- 1.35 vs
. 3.11+/-1.21 ngTK/mu g protein; p = 0.23). No statistical difference in ur
inary tissue kallikrein excretion was observed between normotensive pregnan
t and normotensive non pregnant women (3.02 +/- 1.35 vs. 2.97 +/- 1.12 ngTK
/mu S protein; p = 0.16). Urinary tissue kallikrein excretion correlated po
sitively with urinary creatinine levels at 28 weeks of gestation (r = 0.69;
p < 0.0001) and close to delivery dare (r = 0.84; p < 0.0001). There was n
o correlation between neonatal birthweight and urinary tissue kallilirein l
evels (r = -0.44; p = 0.41).
Conclusion. The decreased levels of urinary tissue kallikrein excretion in
pre-eclamptic patients suggests an etiological role for this serine proteas
e in hypertensive disorders of pregnancy.